Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female Chinese population

Journal of Affective Disorders

Volumn 133, Issue 3, 2011, Pages 619-624

  Shen, Xinhua ^a   Wu, Yanfeng ^b   Qian, Mingcai ^a   Wang, Xiaoquan ^c   Hou, Zhenghua ^c   Liu, Yang ^c   Sun, Jushui ^a   Zhong, Hua ^a   Yang, Jianhong ^a   Lin, Min ^a   Li, Liang ^a   Guan, Tiefeng ^a   Shen, Zhongxia ^a   Yuan, Yonggui ^d  

^a HUZHOU CENTRAL HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d SOUTHEAST UNIVERSITY   (China)

Author keywords

Antidepressant; Haplotype; Major depressive disorder; Polymorphism; Tryptophan hydroxylase 2

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN HYDROXYLASE 2;

ADULT; ARTICLE; CHINESE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PLACEBO EFFECT; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POPULATION GROUPS; TREATMENT OUTCOME; TRYPTOPHAN HYDROXYLASE;

EID: 80052087030     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.04.037     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Washington, DC
2. V. Dolzan, A. Serretti, L. Mandelli, J. Koprivsek, M. Kastelic, and B.K. Plesnicar Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1562 1566
3. J.A. Gingrich, and R. Hen Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice Psychopharmacology (Berl) 155 2001 1 10 (Pubitemid 32295763)
4. C.E. Glatt, E. Carlson, T.R. Taylor, N. Risch, V.I. Reus, and C.A. Schaefer Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 (Neuron 48, 704-705, 705-706)
5. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
6. M. Harvey, E. Shink, M. Tremblay, B. Gagne, C. Raymond, M. Labbe, D.J. Walther, M. Bader, and N. Barden Support for the involvement of TPH2 gene in affective disorders Mol. Psychiatry 9 2004 980 981
7. M. Harvey, B. Gagne, M. Labbe, and N. Barden Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees Psychiatr. Genet. 17 2007 17 22 (Pubitemid 44953342)
8. K.S. Kendler, M. Gatz, C.O. Gardner, and N.L. Pedersen A Swedish national twin study of lifetime major depression Am. J. Psychiatry 163 2006 109 114 (Pubitemid 43050111)
9. J. Kirchheiner, K. Nickchen, M. Bauer, M.L. Wong, J. Licinio, I. Roots, and J. Brockmoller Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response Mol. Psychiatry 9 2004 442 473 (Pubitemid 38903502)
10. G. Laje, and F.J. McMahon The pharmacogenetics of major depression: past, present, and future Biol. Psychiatry 62 2007 1205 1207 (Pubitemid 350060900)
11. J.E. Lim, J. Pinsonneault, W. Sadee, and D. Saffen Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons Mol. Psychiatry 12 2007 491 501 (Pubitemid 46652452)
12. S. Numata, J. Iga, M. Nakataki, S. Tayoshi, T. Tanahashi, M. Itakura, S. Ueno, and T. Ohmori Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese population J. Psychiatry Neurosci. 34 2009 195 198
13. E.J. Peters, S.L. Slager, P.J. McGrath, J.A. Knowles, and S.P. Hamilton Investigation of serotonin-related genes in antidepressant response Mol. Psychiatry 9 2004 879 889 (Pubitemid 39273536)
14. J.L. Rausch, M.E. Johnson, Y.J. Fei, J.Q. Li, N. Shendarkar, H.M. Hobby, V. Ganapathy, and F.H. Leibach Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome Biol. Psychiatry 51 2002 723 732 (Pubitemid 34450808)
15. C.R. Reynolds, M.A. Dew, E.J. Lenze, and E.M. Whyte Preventing depression in medical illness: a new lead? Arch. Gen. Psychiatry 64 2007 884 885 (Pubitemid 47230611)
16. A. Serretti, R. Zanardi, L. Franchini, P. Artioli, D. Dotoli, A. Pirovano, and E. Smeraldi Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up Pharmacogenetics 14 2004 607 613 (Pubitemid 39281815)
17. A. Serretti, A. Chiesa, R. Calati, I. Massat, S. Linotte, S. Kasper, Y. Lecrubier, M. Fink, I. Antonijevic, C. Forray, L. Snyder, J. Bollen, J. Zohar, D. De Ronchi, D. Souery, and J. Mendlewicz No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression Psychiatry Res 2010 10.1016/j.psychres.2010.11.023
18. Y.Y. Shi, and L. He SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci Cell Res. 15 2005 97 98 (Pubitemid 41653949)
19. J. Shi, J.B. Potash, J.A. Knowles, M.M. Weissman, W. Coryell, W.A. Scheftner, W.B. Lawson, J.J. DePaulo, P.V. Gejman, A.R. Sanders, J.K. Johnson, P. Adams, S. Chaudhury, D. Jancic, O. Evgrafov, A. Zvinyatskovskiy, N. Ertman, M. Gladis, K. Neimanas, M. Goodell, N. Hale, N. Ney, R. Verma, D. Mirel, P. Holmans, and D.F. Levinson Genome-wide association study of recurrent early-onset major depressive disorder Mol. Psychiatry 16 2011 193 201
20. S.J. Tsai, C.J. Hong, Y.J. Liou, Y.W. Yu, T.J. Chen, S.J. Hou, and F.C. Yen Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 637 641
21. M.V. Tzvetkov, J. Brockmoller, I. Roots, and J. Kirchheiner Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment Pharmacogenet. Genomics 18 2008 495 506 (Pubitemid 351769917)
22. R. Uher, N. Perroud, M.Y. Ng, J. Hauser, N. Henigsberg, W. Maier, O. Mors, A. Placentino, M. Rietschel, D. Souery, T. Zagar, P.M. Czerski, B. Jerman, E.R. Larsen, T.G. Schulze, A. Zobel, S. Cohen-Woods, K. Pirlo, A.W. Butler, P. Muglia, M.R. Barnes, M. Lathrop, A. Farmer, G. Breen, K.J. Aitchison, I. Craig, C.M. Lewis, and P. McGuffin Genome-wide pharmacogenetics of antidepressant response in the GENDEP project Am. J. Psychiatry 167 2010 555 564
23. A. Van Den Bogaert, S. De Zutter, L. Heyrman, J. Mendlewicz, R. Adolfsson, C. Van Broeckhoven, and J. Del-Favero Response to Zhang et al (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 (Neuron 48, 704, 705-706)
24. P.A. van Zwieten, G.J. Blauw, and P. van Brummelen Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs Clin. Physiol. Biochem. 8 Suppl 3 1990 1 18
25. Xu, Z., Zhang, Z.J., Shi, Y.Y., Pu, M.J., Yuan, Y.G., Zhang, X.R., Li, L.J., Reynolds, G.P., in press. Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. J. Psychopharmacol. (Electronic publication ahead of print).
26. J. You, Y. Yuan, Z. Zhang, X. Zhang, H. Li, and Y. Qian A preliminary association study between brain-derived neurotrophic factor (BDNF) haplotype and late-onset depression in mainland Chinese J. Affect. Disord. 120 2010 165 169
27. X. Zhang, R.R. Gainetdinov, J.M. Beaulieu, T.D. Sotnikova, L.H. Burch, R.B. Williams, D.A. Schwartz, K.R. Krishnan, and M.G. Caron Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 (Pubitemid 40075345)
28. Y. Zhang, C. Zhang, G. Yuan, J. Yao, Z. Cheng, C. Liu, Q. Liu, G. Wan, G. Shi, Y. Cheng, Y. Ling, and K. Li Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression Behav. Brain Funct. 6 2010 49
29. Z. Zhou, E.J. Peters, S.P. Hamilton, F. McMahon, C. Thomas, P.J. McGrath, J. Rush, M.H. Trivedi, D.S. Charney, A. Roy, S. Wisniewski, R. Lipsky, and D. Goldman Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 (Neuron 48, 702-703, 705-706)
30. Z. Zhou, A. Roy, R. Lipsky, K. Kuchipudi, G. Zhu, J. Taubman, M.A. Enoch, M. Virkkunen, and D. Goldman Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations Arch. Gen. Psychiatry 62 2005 1109 1118 (Pubitemid 41396936)
31. P. Zill, T.C. Baghai, P. Zwanzger, C. Schule, D. Eser, R. Rupprecht, H.J. Moller, B. Bondy, and M. Ackenheil SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression Mol. Psychiatry 9 2004 1030 1036 (Pubitemid 39524291)